Status:
NOT_YET_RECRUITING
The Efficacy of Intrathecal Morphine Versus Intrathecal Morphine-Dexamethasone Combination in Cesarean Delivery
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Caesarean Section
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The Efficacy of Intrathecal Morphine Versus Intrathecal Morphine+Dexamethasone Combination added to bupivacaine in elective cesarean section under spinal anesthesia
Detailed Description
The study will be designed as a double-blind, randomized clinical trial and will be conducted following approval by the local ethics committee. A total of 120 patients, aged 18-40 years, with an ASA p...
Eligibility Criteria
Inclusion
- Patients scheduled for caesarean sections
- Between 18-40 years
- ASA II group
- Those who will undergo spinal anesthesia
- Those between 35-40 weeks of pregnancy
- 1st and 2nd caesarean sections
Exclusion
- Those who prefer general anesthesia
- Those who are outside the age range of 18-40
- Those who are ASA III and above
- Those with HT, DM, cardiac and respiratory diseases
- Preeclampsia, eclampsia, HELLP
- Those with a history of drug use that affects the cardiovascular system
- Placenta Previa, Placenta Acreta, Placenta Acreta Those with a history of antiemetic or antidepressant drug use
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06985992
Start Date
July 1 2025
End Date
November 1 2025
Last Update
May 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.